acquires Headstrong $550M - SGNT amended S1 Secondaries (announced/priced): KRC, 2BB, DLLR IPO's (filed/priced): Pimco REIT files $600M through CS, GS & JPM, IPO's (lock-up expires): EFC, GEDU Key Research: Macquarie initiates US Clinical Diagnostic Labs - BRLI/MYGN (neutral) & GHDX/LH/DGX (op) Key Re

LOGM & ZIXI (op's), MS upgrades CRM, Opco initiates AIS (op), Bofa resumes THC (neutral) Key Research: FBR upgrades GTIV, Barclays downgrades NKA, GS & JPM initiates ZIP, Citi initiates ARCO (buy) Reporting Pre-Open: AZO, MDT, BPHX, CBRL, CNTF, DSW, EDAP, HSOL, KUTV, OTIV, PRXI, REDF, SAFM Reporting